GSK profit lifted by HIV, asthma drugs in boost to new CEO
Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectationsPublished Wed, Feb 4, 2026 · 11:13 PM ...
Tag: GSK
GSK plans £2 billion share buyback, boosts long-term outlook
GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism ...
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker ...
GSK surges 6.5% after US$2.2 billion Zantac lawsuits settlement
SHARES of British drugmaker GSK rose as much as 6.5 per cent on Thursday (Oct 10), after it agreed to ...
GSK raises annual profit and sales forecast after second quarter beat
BRITISH drugmaker GSK raised its annual earnings and sales forecasts on Wednesday (Jul 31) and posted second-quarter results that beat ...
UK government snubs GSK in favour of rival RSV shot from Pfizer
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
NEWS
- Business
- Technology
- Entertainment
- Sports
- Lifestyle
- Health
- Politics
- Real Estate
© 2026 The New York Journals. All Rights Reserved.